Literature DB >> 22841288

Evaluation of hepatic tumor response to yttrium-90 radioembolization therapy using texture signatures generated from contrast-enhanced CT images.

Rebekah H Gensure1, David J Foran, Vincent M Lee, Vyacheslav M Gendel, Salma K Jabbour, Darren R Carpizo, John L Nosher, Lin Yang.   

Abstract

RATIONALE AND
OBJECTIVES: The aim of this study was to explore the use of texture features generated from liver computed tomographic (CT) datasets as potential image-based indicators of patient response to radioembolization (RE) with yttrium-90 ((90)Y) resin microspheres, an emerging locoregional therapy for advanced-stage liver cancer.
MATERIALS AND METHODS: Overall posttherapy survival and percent change in serologic tumor marker at 3 months posttherapy represent the primary clinical outcomes in this study. Thirty advanced-stage liver cancer cases (primary and metastatic) treated with RE over a 3-year period were included. Texture signatures for tumor regions, which were delineated to reveal boundaries with normal regions, were computed from pretreatment contrast-enhanced liver CT studies and evaluated for their ability to classify patient serologic response and survival.
RESULTS: A series of systematic leave-one-out cross-validation studies using soft-margin support vector machine (SVM) classifiers showed hepatic tumor texton and local binary pattern (LBP) signatures both achieve high accuracy (96%) in discriminating subjects in terms of their serologic response. The image-based indicators were also accurate in classifying subjects by survival status (80% and 93% accuracy for texton and LBP signatures, respectively).
CONCLUSIONS: Hepatic texture signatures generated from tumor regions on pretreatment triphasic CT studies were highly accurate in differentiating among subjects in terms of serologic response and survival. These image-based computational markers show promise as potential predictive tools in candidate evaluation for locoregional therapy such as RE.
Copyright © 2012 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22841288      PMCID: PMC3438382          DOI: 10.1016/j.acra.2012.04.015

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  23 in total

1.  A global geometric framework for nonlinear dimensionality reduction.

Authors:  J B Tenenbaum; V de Silva; J C Langford
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

2.  A texton-based approach for the classification of lung parenchyma in CT images.

Authors:  Mehrdad J Gangeh; Lauge Sørensen; Saher B Shaker; Mohamed S Kamel; Marleen de Bruijne; Marco Loog
Journal:  Med Image Comput Comput Assist Interv       Date:  2010

3.  Adaptive discriminant wavelet packet transform and local binary patterns for meningioma subtype classification.

Authors:  Hammad Qureshi; Olcay Sertel; Nasir Rajpoot; Roland Wilson; Metin Gurcan
Journal:  Med Image Comput Comput Assist Interv       Date:  2008

Review 4.  Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.

Authors:  Riad Salem; Kenneth G Thurston
Journal:  J Vasc Interv Radiol       Date:  2006-08       Impact factor: 3.464

5.  Diagnosis of hepatic tumors with texture analysis in nonenhanced computed tomography images.

Authors:  Yu-Len Huang; Jeon-Hor Chen; Wu-Chung Shen
Journal:  Acad Radiol       Date:  2006-06       Impact factor: 3.173

6.  Heterogeneity in DCE-MRI parametric maps: a biomarker for treatment response?

Authors:  L Alic; M van Vliet; C F van Dijke; A M M Eggermont; J F Veenland; W J Niessen
Journal:  Phys Med Biol       Date:  2011-02-18       Impact factor: 3.609

7.  Computational pathology analysis of tissue microarrays predicts survival of renal clear cell carcinoma patients.

Authors:  Thomas J Fuchs; Peter J Wild; Holger Moch; Joachim M Buhmann
Journal:  Med Image Comput Comput Assist Interv       Date:  2008

8.  Yttrium-90 radioembolization for liver malignancies: prognostic factors associated with survival.

Authors:  Brian L Dunfee; Ahsun Riaz; Robert J Lewandowski; Saad Ibrahim; Mary F Mulcahy; Robert K Ryu; Bassel Atassi; Kent T Sato; Steven Newman; Reed A Omary; Al Benson; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2009-11-25       Impact factor: 3.464

9.  Hepatic enhancement in colorectal cancer: texture analysis correlates with hepatic hemodynamics and patient survival.

Authors:  Balaji Ganeshan; Kenneth A Miles; Rupert C D Young; Chris R Chatwin
Journal:  Acad Radiol       Date:  2007-12       Impact factor: 3.173

10.  Selective internal radiation therapy (SIRT): a new modality for treating patients with colorectal liver metastases.

Authors:  R S Stubbs; S K Wickremesekera
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

View more
  4 in total

1.  CT texture analysis in colorectal liver metastases: A better way than size and volume measurements to assess response to chemotherapy?

Authors:  Sheng-Xiang Rao; Doenja Mj Lambregts; Roald S Schnerr; Rianne Cj Beckers; Monique Maas; Fabrizio Albarello; Robert G Riedl; Cornelis Hc Dejong; Milou H Martens; Luc A Heijnen; Walter H Backes; Geerard L Beets; Meng-Su Zeng; Regina Gh Beets-Tan
Journal:  United European Gastroenterol J       Date:  2015-08-21       Impact factor: 4.623

Review 2.  False Discovery Rates in PET and CT Studies with Texture Features: A Systematic Review.

Authors:  Anastasia Chalkidou; Michael J O'Doherty; Paul K Marsden
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

Review 3.  Quantification of heterogeneity as a biomarker in tumor imaging: a systematic review.

Authors:  Lejla Alic; Wiro J Niessen; Jifke F Veenland
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

4.  Tumor response prediction in 90Y radioembolization with PET-based radiomics features and absorbed dose metrics.

Authors:  Lise Wei; Can Cui; Jiarui Xu; Ravi Kaza; Issam El Naqa; Yuni K Dewaraja
Journal:  EJNMMI Phys       Date:  2020-12-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.